124 related articles for article (PubMed ID: 38042284)
1. Identification and validation of chromatin regulator-related signatures as a novel prognostic model for low-grade gliomas using translational bioinformatics.
Wang B; Feng Y; Li Z; Zhou F; Luo J; Yang B; Long S; Li X; Liu Z; Li X; Chen J; Wang L; Wei W
Life Sci; 2024 Jan; 336():122312. PubMed ID: 38042284
[TBL] [Abstract][Full Text] [Related]
2. A novel risk score model based on fourteen chromatin regulators-based genes for predicting overall survival of patients with lower-grade gliomas.
Zhang Y; Yu B; Tian Y; Ren P; Lyu B; Fu L; Chen H; Li J; Gong S
Front Genet; 2022; 13():957059. PubMed ID: 36246611
[No Abstract] [Full Text] [Related]
3. Prognostic value of γ-aminobutyric acidergic synapse-associated signature for lower-grade gliomas.
Jiang H; Sun Z; Li F; Chen Q
Front Immunol; 2022; 13():983569. PubMed ID: 36405708
[TBL] [Abstract][Full Text] [Related]
4. Positive regulators of T cell functions as predictors of prognosis and microenvironment characteristics of low-grade gliomas.
Li Y; Feng Y; Luo F; Peng G; Li Y
Front Immunol; 2022; 13():1089792. PubMed ID: 36726969
[TBL] [Abstract][Full Text] [Related]
5. Characterization of DNA Damage Repair Related Signature and Molecular Feature in Low-Grade Gliomas to Aid Chemotherapy and Drug Discovery.
Yin X; Li M; He Z
Front Biosci (Landmark Ed); 2023 Oct; 28(10):234. PubMed ID: 37919061
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of the clinical and biological significances of cholesterol metabolism in lower-grade gliomas.
Tao R; Huang R; Yang J; Wang J; Wang K
BMC Cancer; 2023 Jul; 23(1):692. PubMed ID: 37488496
[TBL] [Abstract][Full Text] [Related]
7. Modification Patterns of DNA Methylation-Related lncRNAs Regulating Genomic Instability for Improving the Clinical Outcomes and Tumour Microenvironment Characterisation of Lower-Grade Gliomas.
Maimaiti A; Aili Y; Turhon M; Kadeer K; Aikelamu P; Wang Z; Niu W; Aisha M; Kasimu M; Wang Y; Wang Z
Front Mol Biosci; 2022; 9():844973. PubMed ID: 35359593
[No Abstract] [Full Text] [Related]
8. RNA processing genes characterize RNA splicing and further stratify lower-grade glioma.
Chai RC; Li YM; Zhang KN; Chang YZ; Liu YQ; Zhao Z; Wang ZL; Chang YH; Li GZ; Wang KY; Wu F; Wang YZ
JCI Insight; 2019 Aug; 5(17):. PubMed ID: 31408440
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Characterization of Pyroptosis Patterns with Implications in Prognosis and Immunotherapy in Low-Grade Gliomas.
Zhou Z; Wei J; Lu B; Jiang W; Bao Y; Li L; Wang W
Front Genet; 2021; 12():763807. PubMed ID: 35198000
[No Abstract] [Full Text] [Related]
10. A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas.
Wu Y; Peng Z; Gu S; Wang H; Xiang W
Comput Math Methods Med; 2022; 2022():2558548. PubMed ID: 35186111
[TBL] [Abstract][Full Text] [Related]
11. Immune-Related Gene SERPINE1 Is a Novel Biomarker for Diffuse Lower-Grade Gliomas
Huang X; Zhang F; He D; Ji X; Gao J; Liu W; Wang Y; Liu Q; Xin T
Front Oncol; 2021; 11():646060. PubMed ID: 34094933
[TBL] [Abstract][Full Text] [Related]
12. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
Zhao WJ; Ou GY; Lin WW
Front Immunol; 2021; 12():682415. PubMed ID: 34054873
[TBL] [Abstract][Full Text] [Related]
13. N7-methylguanosin regulators-mediated methylation modification patterns and characterization of the immune microenvironment in lower-grade glioma.
Maimaiti A; Feng Z; Liu Y; Turhon M; Xie Z; Baihetiyaer Y; Wang X; Kasimu M; Jiang L; Wang Y; Wang Z; Pei Y
Eur J Med Res; 2023 Mar; 28(1):144. PubMed ID: 36998056
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Characterization of a Novel E3-Related Gene Signature With Implications in Prognosis and Immunotherapy of Low-Grade Gliomas.
Tan S; Spear R; Zhao J; Sun X; Wang P
Front Genet; 2022; 13():905047. PubMed ID: 35832194
[TBL] [Abstract][Full Text] [Related]
15. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
[TBL] [Abstract][Full Text] [Related]
16. Identification of a chromatin regulator signature and potential prognostic ability for adrenocortical carcinoma.
Li J; Jia Y; Tang L; Zhang R; Zhang Y
Front Genet; 2022; 13():948353. PubMed ID: 36092868
[No Abstract] [Full Text] [Related]
17. Identification of heterogeneous subtypes and a prognostic model for gliomas based on mitochondrial dysfunction and oxidative stress-related genes.
Li J; Wang S; Chi X; He Q; Tao C; Ding Y; Wang J; Zhao J; Wang W
Front Immunol; 2023; 14():1183475. PubMed ID: 37334354
[TBL] [Abstract][Full Text] [Related]
18. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma.
Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X
Front Genet; 2022; 13():872186. PubMed ID: 35937991
[No Abstract] [Full Text] [Related]
19. Identification of molecular subtypes based on chromatin regulator and tumor microenvironment infiltration characterization in papillary renal cell carcinoma.
Tang Q; Pan D; Xu C; Chen L
J Cancer Res Clin Oncol; 2023 Jan; 149(1):231-245. PubMed ID: 36404389
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial RNA modification-based signature to predict prognosis of lower grade glioma: a multi-omics exploration and verification study.
Zhou X; Ling Y; Cui J; Wang X; Long N; Teng W; Liu J; Xiang X; Yang H; Chu L
Sci Rep; 2024 Jun; 14(1):12602. PubMed ID: 38824202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
